OverviewSuggest Edit

Ablacon is an AI-based provider of atrial fibrillation therapy. The Company uses a machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation. It is a real-time high-precision AI-guided diagnosis system.

TypePrivate
Founded2015
HQWheat Ridge, CO, US
Websiteablacon.com

Latest Updates

Employees (est.) (Jul 2021)29(-3%)
Cybersecurity ratingAMore

Key People/Management at Ablacon

Martin Grasse

Martin Grasse

COO

Ablacon Office Locations

Ablacon has offices in Wheat Ridge, München and Lausanne
Wheat Ridge, CO, US (HQ)
4800 Wadsworth Blvd, Suite 310
München, DE
Walter-Gropius-Straße 17
Show all (3)

Ablacon Financials and Metrics

Summary Metrics

Founding Date

2015

Ablacon total Funding

$33.5 m

Ablacon latest funding size

$10 m

Time since last funding

2 years ago

Ablacon investors

Ablacon's latest funding round in July 2019 was reported to be $10 m. In total, Ablacon has raised $33.5 m
Show all financial metrics

Ablacon Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Ablacon Online and Social Media Presence

Embed Graph

Ablacon News and Updates

Ablacon, Inc. Announces $30 Million Series B Financing and Expansion of Scientific Advisory Board

MENLO PARK, Calif., Jan. 7, 2021 /PRNewswire/ -- Ablacon, Inc., an Ajax Health-backed company, announced the close of a $30 million Series B financing, with Zeus Health joining as new lead investor. Ablacon also announced the addition of Dr. David Haines, Professor of Cardiovascular...

Ablacon, Inc. Announces the Formation of Scientific Advisory Board

MENLO PARK, Calif., June 23, 2020 /PRNewswire/ -- Ablacon, Inc., an Ajax Health-backed company, announced today the formation of its Scientific Advisory Board (SAB). The SAB will be composed of four internationally recognized thought leaders in the field of electrophysiology to guide...

Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark

MENLO PARK, Calif., Sept. 10, 2019 /PRNewswire/ -- Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology under the company's existing CE Mark. The new update includes an enhanced physician experience and...

Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company

MENLO PARK, Calif., July 23, 2019 /PRNewswire/ -- Ablacon Inc. announced today that it has entered into a $10 million venture debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2 million equity investment in the Company. This financing will help fund...

Ablacon Blogs

First-in-man demonstration of 18-month spatiotemporal stability of active atrial fibrillation source detected by Electrographic Flow mapping in persistent atrial fibrillation

The aim of this first-in-man Case report is to demonstrate the spatiotemporal stability and long-term reproducibility of a putative AF source in a patient suffering from long-standing persistent AF associated with hypertrophic cardiomyopathy, by comparing EGF maps recorded 18 months apart. The post …

Functional Electrographic Flow Patterns in Patients with Persistent Atrial Fibrillation Predict Outcome of Catheter Ablation

Electrographic flow (EGF) mapping is a method to detect action potential sources within the atria. In a double-blinded retrospective study we evaluated whether sources detected by EGF are related to procedural outcome. The post Functional Electrographic Flow Patterns in Patients with Persistent Atri…

$30 Million Series B Financing and Expansion of Scientific Advisory Board

Ablacon, Inc., an Ajax Health-backed company, announced the close of a $30 million Series B financing, with Zeus Health joining as new… The post $30 Million Series B Financing and Expansion of Scientific Advisory Board appeared first on Ablacon.

Ablacon Frequently Asked Questions

  • When was Ablacon founded?

    Ablacon was founded in 2015.

  • Who are Ablacon key executives?

    Ablacon's key executives are Martin Grasse.

  • How many employees does Ablacon have?

    Ablacon has 29 employees.

  • Who are Ablacon competitors?

    Competitors of Ablacon include FibriCheck, Corhythm and LiveMetric.

  • Where is Ablacon headquarters?

    Ablacon headquarters is located at 4800 Wadsworth Blvd, Suite 310, Wheat Ridge.

  • Where are Ablacon offices?

    Ablacon has offices in Wheat Ridge, München and Lausanne.

  • How many offices does Ablacon have?

    Ablacon has 3 offices.